| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Wright Christopher I Director | Sale | -2,000 | -7.23%25,680 | $45.10 | $90,200 | View SEC filing | |
| 2026-06-04 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | -2,034 | -0.88%229,524 | $43.05 | $87,564 | View SEC filing | |
| 2026-06-01 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -10.42%77,389 | $41.67 | $375,044 | View SEC filing | |
| 2026-05-29 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | -16,217 | -67.76%7,717 | $42.36 | $687,007 | View SEC filing | |
| 2026-05-04 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | -2,034 | -0.87%231,558 | $33.20 | $67,529 | View SEC filing | |
| 2026-05-01 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -9.96%81,389 | $33.40 | $300,560 | View SEC filing | |
| 2026-04-06 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | -2,034 | -0.86%233,592 | $34.57 | $70,315 | View SEC filing | |
| 2026-04-01 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -9.54%85,389 | $35.51 | $319,604 | View SEC filing | |
| 2026-03-04 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | -6,890 | -47.17%7,717 | $29.29 | $201,808 | View SEC filing | |
| 2026-03-04 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale | -6,000 | -5.18%109,769 | $30.00 | $180,000 | View SEC filing | |
| 2026-03-04 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -9.15%89,389 | $29.72 | $267,485 | View SEC filing | |
| 2026-03-04 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | -4,068 | -1.70%235,626 | $29.52 | $120,108 | View SEC filing | |
| 2026-02-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -13.49%57,740 | $33.93 | $305,385 | View SEC filing | |
| 2026-02-02 | Cooke Shane Director | Sale | -61,200 | -37.10%103,744 | $34.57 | $2,115,673 | View SEC filing | |
| 2026-01-08 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -5,000 | -7.49%61,740 | $30.00 | $150,005 | View SEC filing | |
| 2026-01-02 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -4,000 | -6.08%61,740 | $28.00 | $112,000 | View SEC filing | |
| 2025-12-05 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -3,748 | -5.39%65,740 | $30.00 | $112,447 | View SEC filing | |
| 2025-12-01 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -4,000 | -5.74%65,740 | $29.30 | $117,200 | View SEC filing | |
| 2025-11-03 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -11.43%69,740 | $30.38 | $273,442 | View SEC filing | |
| 2025-10-15 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -9,000 | -10.88%73,740 | $31.53 | $283,776 | View SEC filing | |
| 2025-06-10 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale | -6,667 | -7.18%86,208 | $31.52 | $210,143 | View SEC filing | |
| 2025-02-28 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | -1,938 | -20.07%7,717 | $34.00 | $65,892 | View SEC filing | |
| 2025-02-25 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | -3,743 | -32.66%7,717 | $35.26 | $131,978 | View SEC filing | |
| 2025-02-20 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | -1,327 | -14.67%7,717 | $35.69 | $47,361 | View SEC filing | |
| 2025-02-14 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | -349,340 | -77.98%57,875 | $33.92 | $11,848,975 | View SEC filing |
1-25 of 538
